BridgeMD
Tests treatment safety and results for Postoperative Pain
Official title Efficacy of Preventive Ketamine on Postoperative Pain
ClinicalTrials.gov ID: NCT04908579
What this study is testing
What is bupivacaine(intraperitoneally) and ketamine (intraperitoneally)?
bupivacaine(intraperitoneally) and ketamine (intraperitoneally) is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for postoperative pain.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Although bariatric surgery is mainly performed laparoscopically, analgesic optimization is still essential to reduce complications and to improve the patients' comfort. In laparoscopic sleeve gastrectomy, the intraoperative peritoneal instillation of bupivacaine hydrochloride (30 ml, 0.25%) was known to be safe and effective in reducing postoperative pain, nausea, and vomiting.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 60
You may be able to join if
- \- Body mass index \> 35 and \< 60 kg/m2
- Either medically free or with well controlled hypertension and/or diabetes.
You likely can't join if
- \- Patient's refusal to participate in the study
- BMI \> 60 kg/m2.
- Age less than 21 years.
- Patients with severe systemic disease which is not life-threatening.
- Patients on antipsychotics, antidepressants and/or corticosteroids.
- Patients with history of obstructive sleep apnea.
See the full eligibility criteria
- \- Body mass index \> 35 and \< 60 kg/m2
- Either medically free or with well controlled hypertension and/or diabetes.
- \- Patient's refusal to participate in the study
- BMI \> 60 kg/m2.
- Age less than 21 years.
- Patients with severe systemic disease which is not life-threatening.
- Patients on antipsychotics, antidepressants and/or corticosteroids.
- Patients with history of obstructive sleep apnea.
- Allergic reaction to any of the study medications.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.